1-7 of 7
Rosana A Silveira
Close
Sort by
Journal Articles

Early Molecular Response Is Predictive Of Overall, Progression-Free and Event-Free Survival In Chronic Myeloid Leukemia Using Second-Generation Tyrosine Kinase Inhibitors After Imatinib Treatment

Beatriz F Ribeiro, Bruna Vergilio, Eliana C M Miranda, MEd, Maria Helena Almeida, RN, Marcia Torresan Delamain, MD, Rosana A Silveira, MSc, Carmino A De Souza, Sr., MD, PhD, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Andrey dos Santos, PhD, Irene Lorand-Metze, MD, PhD, Vagner O Duarte, Gislaine O. Duarte, PhD, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1326.
https://doi.org/10.1182/blood.V122.21.1326.1326
Published: 2013
Journal Articles

Treatment Results With Dasatinib Or Nilotinib In Third Line Therapy Of Chronic Myeloid Leukemia After Failure Of Two Tyrosine Kinase Inhibitors

Beatriz F Ribeiro, Eliana C M Miranda, MEd, Marcia T Delamain, MD, Gislaine Borba Oliveira, MD,, Maria Helena Almeida, RN, Vagner O Duarte, Irene L Metze, MD, PhD, Carmino A De Souza, Sr., MD, PhD, Rosana A Silveira, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5189.
https://doi.org/10.1182/blood.V122.21.5189.5189
Published: 2013
Journal Articles

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

Katia B. Pagnano, MD, Israel Bendit, MD, Carla Boquimpani, Carmino Antonio De Souza, MD, PhD, Eliana C M Miranda, Rosana A Silveira, Vaneuza A M Funke, MD, Ricardo Pasquini, MD, Vania Hungria, MD, Nelma Clementino, MD, Monika Conchon, Elena B Moiraghi, MD, Jose L. Lopez, MD, Carolina Pavlovsky, MD, Eduardo Cervera, Belinda Pinto Simoes, MD, PhD, Luis A Meillon, MD, Nelson Spector, MD, PhD, Nelson Hamerschlak, MD, Miguel Pavlovsky, Alicia Magarinos, MD, Vagner O Duarte, Ernesto M Fanilla, Jorge E. Cortes, Raquel Bengió, MD
Journal: Blood
Blood (2011) 118 (21): 1701.
https://doi.org/10.1182/blood.V118.21.1701.1701
Published: 2011
Journal Articles

Gene Expression Profile in Responsive and Non-Responsive Chronic Myeloid Leukemia Patients Treated with Dasatinib.

Rosana A Silveira, MSc, Angela A Fachel, Yuri B Moreira, Marcia T Delamain, MD, Carmino Antonio De Souza, MD, PhD, Fernando Ferreira Costa, Ph.D., M.D., Sergio Verjovski-Almeida, MD, PhD, Katia B.B. Pagnano, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3260.
https://doi.org/10.1182/blood.V114.22.3260.3260
Published: 2009
Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia with T315I BCR-ABL Mutation

Kati a BB Pagnano, MD, PhD, Rosana A Silveira, Luciana Nardinelli, Monika Conchon, MD, PhD, Carmino De Souza, MD, PhD, Pedro ED Llacer, MD, Phd, Irene Lorand-Metze, MD, PhD, Vaneuza Funke, MD, Ricardo Pasquini, MD, PhD, Cintia C Mascarenhas, Maria Aparecida Zanichelli, MD, Phd, Nelma CD Clementino, MD, PhD, Israel Bendit, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4262.
https://doi.org/10.1182/blood.V112.11.4262.4262
Published: 2008
Journal Articles

Screening of Mutations in BCR-ABL Kinase Domain in Chronic Myeloid Leukemia (CML) Patients Treated with Kinase Inhibitors by Denaturing High-Performance Liquid Chromatography (D-HPLC).

Cintia C. Mascarenhas, Anderson F. Cunha, Katia B.B. Pagnano, MD, Rosana A. Silveira, Fernando F. Costa, MDPhD, Ricardo Pasquini, MDPhD, Nelma C.D. Clementino, MDPhD, Carmino A. De Souza, MDPhD
Journal: Blood
Blood (2007) 110 (11): 4580.
https://doi.org/10.1182/blood.V110.11.4580.4580
Published: 2007
Journal Articles

Detection of BCR-ABL Point Mutations in Patients with Chronic Myeloid Leukemia (CML) Resistant to Imatinib.

Rosana A. Silveira, Dulcineia M. Albuquerque, PhD, Angela M. Assis, Edson Ichihara, Carmino A. de Souza, MD,PhD, Fernando F. Costa, MD,PhD, Marcia T. Delamain, MD, Afonso C. Vigorito, MD,PhD, Irene Lorand-Metze, MD,PhD, Eliana Miranda, Katia B.B. Pagnano, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 4817.
https://doi.org/10.1182/blood.V108.11.4817.4817
Published: 2006